Keynumbers for: Yield Life Science

 6/30/200912/31/20096/30/201012/31/20106/30/201112/31/20116/30/201212/31/2012
Number of months that the report spans612612612612
Total revenue (MSEK)-0.030.110.1100.200.751.09
Earnings before interest and taxes (EBIT) (MSEK)-1.304-1.915-1.15-2.12-0.75-2.150.240.28
Pre tax profit (PTP) (MSEK)-0.981-1.915-1.15-2.12-0.76-2.760.150.18
Net Revenue (MSEK)-1.304-2.3791.53-6.70-0.77-2.760.150.18
Earnings per share (SEK)0.00-0.250.16-0.70-0.08-0.240.010.01
Dividend per share (SEK)--------
Owner's equity (MSEK)52.59551.4823.5613.0212.0913.9214.0716.56
Fixed assets (MSEK)60.15059.9-12.5512.4913.3413.2315.77
Intangible assets (MSEK)-------15.77
Liquid assets (MSEK)0.4210.662-2.311.610.790.980.97
Total shareholder equity and liabilities (MSEK)----14.1014.1314.2216.74
Long time debts including distributions (MSEK)7.6807.681.160.160---
Short term debt (MSEK)0.2961.501.201.682.010.210.140.11
The share's ratio value (SEK)0.020.020.060.600.600.600.60.6
Cash flow for the period (MSEK)-----0.59-0.42-0.150.55
Number of shares (in millions)----11 472 29411 472 29411 472 29412 319 335
Average number of employees11111110

  • Danderydsgatan 10
  • 114 86 Stockholm
  • Telefon: 08 - 545 038 00
  • Fax: 08 - 611 35 62
  • info(snabel-a)aktietorget(punkt)se